NEO-TRA1

N/A

Report date: 2025/01/26 17:36:26

Base Information

Drug NameNEO-TRA1
Drug Alias NameNEO-TRA1
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionInterleukin-2 receptor alpha chain inhibitors
TargetsInterleukin-2 receptor alpha chain
Therapy Area/IndicationsInflammationGraft vs Host DiseaseAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeoleukin Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeurogene Inc
Inactive CompaniesNeoleukin Therapeutics Inc
Active IndicationsInflammationGraft vs Host DiseaseAutoimmune Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A